[Clinical evaluation of cefminox in surgery].
Cefminox (CMNX, MT-141) was administered to 7 cases with postoperative infections including subphrenic abscess and wound abscess, and the clinical effect was good in 2 cases, fair in 2, poor in 2 and unknown in 1. A daily dose was 2 g in 7 cases. The maximum total dose and duration were 22 g and 11 days respectively. Side effect which was observed during the test period was 1 case of drug eruption. No abnormal laboratory findings related to this drug were noted.
D000328:Adult; D000368:Aged; D002513:Cephamycins / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D013369:Subphrenic Abscess / Q000188:drug therapy / Q000473:pathology; D013530:Surgical Wound Infection / Q000188:drug therapy* / Q000517:prevention & control
D002513:Cephamycins; C046079:cefminox